November 04, 2013
Takeda Pharmaceutical Co. Ltd. on Friday scored victories in three of its patent infringement suits in California federal court against drugmakers looking to sell a generic version of its acid reflux medicine Dexilant, convincing the court that a total of four of its patents would be infringed if the generics went to market.
November 16, 2012
Takeda Pharmaceutical Co. Ltd. has determined that a generic rival's pursuit of a competing version of the Dexilant acid reflux treatment does not infringe a handful of its patents, according to a California federal court's Friday filing entering judgment for the generic drugmaker for four of Takeda's six asserted patents.